Sandoz partnered with Axios to host an Expert Voices Roundtable to discuss a path forward to ease drug shortages and improve patient access to generics.
The 3-in-1 self-test is intended for the qualitative detection and differentiation of nucleocapsid protein antigens from influenza type A and type B as well as SARS-CoV-2.